This website uses cookies
Read our Privacy policy and Terms of use for more information.
Go beyond the BioAge headline. See the score, evidence and logic behind each decision, then use the same 25-Gate framework to compare longevity biotechs on an apples-to-apples basis.
✓ Get the 25-Gate score and evidence behind every Tracker or Scout decision
Through September 6, 2026, 21 companies had earned permanent admission: 11 entered Tracker, 10 entered Scout, and one Scout was later promoted. See why each advanced, what failed to clear the screen, and the evidence that could change the decision. Five later reached verified development milestones; one triggered a financing-risk warning. Past framework outcomes do not predict future results.
Active members may request one company at a time for 25-Gate review at no additional charge. Requests are considered for the research schedule; submission does not guarantee coverage or a favorable conclusion. Educational research only, not investment advice. No return is guaranteed.